Intensity Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INTS and other ETFs, options, and stocks.About INTS
Intensity Therapeutics, Inc. operates as biotechnology company, which develops novel immune-based therapeutic products for cancer treatment. Its product, INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine.
CEOLewis H. Bender
CEOLewis H. Bender
Employees16
Employees16
HeadquartersShelton, Connecticut
HeadquartersShelton, Connecticut
Founded2012
Founded2012
Employees16
Employees16
INTS Key Statistics
Market cap7.34M
Market cap7.34M
Price-Earnings ratio-0.27
Price-Earnings ratio-0.27
Dividend yield—
Dividend yield—
Average volume1.87M
Average volume1.87M
High today$0.29
High today$0.29
Low today$0.2834
Low today$0.2834
Open price$0.31
Open price$0.31
Volume22.17K
Volume22.17K
52 Week high$5.10
52 Week high$5.10
52 Week low$0.2602
52 Week low$0.2602
People also own
Based on the portfolios of people who own INTS. This list is generated using Robinhood data, and it’s not a recommendation.